-

United States Direct Carrier Billing Platform Market Report 2020-2024: Market is Poised to Grow by $ 2.70 Billion, Progressing at a CAGR of 18% - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Direct Carrier Billing Platform Market in US 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The direct carrier billing platform market in US is poised to grow by $ 2.70 bn during 2020-2024 progressing at a CAGR of 18% during the forecast period.

The reports on direct carrier billing platform market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current us market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising popularity of subscription model of paid streaming services, increased adoption of direct carrier billing platform in the mobile gaming industry, and cost advantage through economies of scale. In addition, rising popularity of subscription model of paid streaming services is anticipated to boost the growth of the market as well.

The direct carrier billing platform market in US analysis include end-user segments.

This study identifies the growing demand for mobile identity solutions as one of the prime reasons driving the direct carrier billing platform market in US growth during the next few years. Also, increase in M&A and strategic alliances among vendors, and growth of m-commerce in the us will lead to sizable demand in the market.

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading direct carrier billing platform market in US vendors that include Amdocs Ltd., Apigate Sdn Bhd, Bango Plc, Boku Inc., Centili Ltd., Comviva Technologies Ltd., Digital Turbine Inc., DOCOMO Digital Ltd., Fortumo OU, and Oracle Corp..

Also, the direct carrier billing platform market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Key Topics Covered:

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

Market Segmentation by End-user

  • Market segments
  • Comparison by End-user
  • Apps and games - Market size and forecast 2019-2024
  • Online media - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by End-user

Market Segmentation by Market participants

  • Market segments
  • Comparison by Market participants
  • Content creators - Market size and forecast 2019-2024
  • Merchants - Market size and forecast 2019-2024
  • Carrier networks - Market size and forecast 2019-2024
  • Platform providers - Market size and forecast 2019-2024
  • Market opportunity by Market participants

Customer landscape

  • Customer landscape
  • Market drivers - Demand led growth
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Amdocs Ltd.
  • Apigate Sdn Bhd
  • Bango Plc
  • Boku Inc.
  • Centili Ltd.
  • Comviva Technologies Ltd.
  • Digital Turbine Inc.
  • DOCOMO Digital Ltd.
  • Fortumo OU
  • Oracle Corp.

Appendix

For more information about this report visit https://www.researchandmarkets.com/r/d8phw3

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom